GlassScriptPhysician profile
Louis Leo Bowman
NPI 1366439325
$2,494.98
in general payments reported to CMS, 2019-2025
16 companies · $359 in 2025
The $359 reported for 2025 was more than what 90% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $163 · 2021: $408 · 2022: $69.67 · 2023: $409 · 2024: $685 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $595.39 | 2021-2025 | Austedo Xr, Austedo Xr |
| Braeburn INC. | $553.77 | 2023-2025 | Brixadi |
| Astrazeneca Pharmaceuticals LP | $179.40 | 2021-2024 | Airsupra |
| Orexo US, INC. | $153.71 | 2019 | |
| Uswm, LLC | $146.72 | 2021-2023 | Lucemyra, Zimhi |
| Sunovion Pharmaceuticals INC. | $144.48 | 2019-2021 | |
| Smith+Nephew, INC. | $134.77 | 2019 | |
| Alexion Pharmaceuticals, INC. | $121.90 | 2024 | Koselugo |
| Otsuka America Pharmaceutical, INC. | $121.13 | 2023 | Rexulti |
| Indivior INC. | $101.30 | 2020-2025 | Sublocade |
| Genentech USA, INC. | $82.32 | 2020-2021 | |
| Amgen INC. | $61.95 | 2019 | |
| Mdd US Operations, LLC | $55.77 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $16.49 | 2025 | |
| Tactile Systems Technology INC | $14.16 | 2025 | Flexitouch Plus, Nimbl |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.